Given the scarcity of knowledge in this area, our main objective was to study how JPH2 variants associated with different types of cardiomyopathies (i.e., HCM and DCM) impact lipid metabolism in the heart. The gene discussed is JPH2; the disease is familial dilated cardiomyopathy.